Aug 10, 2024, 13:45
Katsuaki Maehara: EGFR mutated NSCLC
Katsuaki Maehara, Director of Medical Education Colleagues shared a post on X:
“EGFR mutated NSCLC.
This article is the latest data to analyze the concomitant driver alteration of EGFR mutated NSCLC using NGS.
It is also an important dictionary for selecting effective treatment regimens from the analysis results and for encouraging the development of combination therapies.
For all patients with EGFR mutation-positive disease.”
Source: Katsuaki Maehara/X
Landscape of Concomitant Driver Alterations in Classical EGFR-Mutated Non–Small Cell Lung Cancer.
Authors: Huaying Wang, Lie Lin, Chuqiao Liang, Jiaohui Pang, Jiani C. Yin, Junli Zhang, Yang Shao, Chengming Sun, and Renhua Guo.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 8, 2025, 07:59
Aug 8, 2025, 05:47
Aug 8, 2025, 05:01